Baltimore, MDNCT07278388Now EnrollingIRB Ready

PASC Post Acute Sequelae of COVID 19 Clinical Trial in Baltimore, MD

Access cutting-edge pasc post acute sequelae of covid 19 treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.

Sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Quick Self-Assessment

See if you qualify for this Baltimore location

Preparing your pre-screening questions…

Expert Care in Baltimore

Access pasc post acute sequelae of covid 19 specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related pasc post acute sequelae of covid 19 treatment provided free

Apply for This Baltimore Location

Check if you qualify for this pasc post acute sequelae of covid 19 clinical trial in Baltimore, MD

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Baltimore

    Convenient for MD residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Baltimore site if eligible
  4. 4Begin participation

About This PASC Post Acute Sequelae of COVID 19 Study in Baltimore

This proposal aims to understand the neurobiological mechanisms of fatigue in individuals with Post-Acute Sequelae of SARS-CoV-2 Infection (PASC). This knowledge will eventually provide candidate mechanisms to target with pharmacological intervention and inform rehabilitative care for those individuals suffering from symptoms of fatigue in PASC.

Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Who Can Participate

Inclusion Criteria

Age 18 to 75 years old.
Have received a clinical diagnosis of post-acute sequelae of SARS-CoV-2 (PASC)/long COVID syndrome using the criteria specified by Thaweethai, et al., 2023 (JAMA). This symptom checklist provides a score based on the number and severity of symptoms. An individual with a score \>12 is classified as having PASC.
Currently experiencing Fatigue/Brain Fog as assessed with the Post-COVID symptom checklist and the PedsQL questionnaire.

Exclusion Criteria

Neurological disorders including, but not limited to, stroke, head injury, epilepsy, seizures, brain tumors, brain surgery, Parkinson's Disease, or any other neuromuscular disease (self-report).
Diagnosed history of severe psychiatric diseases such as depression and schizophrenia (self-report).
Congestive heart failure.
Peripheral artery disease with claudication.
Pulmonary or renal failure.
Unstable angina.
Uncontrolled hypertension (more than 190/110 mmHg).
Severe aphasia.
Orthopedic or pain conditions.
Have had exposure to metal or metal implants, due to the hazardous effects of the magnetic field.
If on immunomodulatory therapy, they must have been on that therapy for at least 6 months before the start of the study. Healthy age- and sex-matched controls for PASC - Exclusion criteria: Participants with a history of any of the following will be excluded from the study:
Hospitalization due to SARS-CoV-2 infection.
Neurological disorders including, but not limited to, stroke, head injury, epilepsy, seizures, brain tumors, brain surgery, Parkinson's Disease, or any other neuromuscular disease (self-report).
Diagnosed history of severe psychiatric diseases such as depression and schizophrenia (self-report).
Congestive heart failure.
Peripheral artery disease with claudication.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Baltimore?

Yes, this clinical trial (NCT07278388) has an active research site in Baltimore, MD that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

PASC Post Acute Sequelae of COVID 19 Treatment Options in Baltimore, MD

If you're searching for pasc post acute sequelae of covid 19 treatment options in Baltimore, MD, this clinical trial (NCT07278388) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pasc post acute sequelae of covid 19 specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all pasc post acute sequelae of covid 19 clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Baltimore, MD

See all ankylosing spondylitis clinical trials recruiting in Baltimore — not just this study.

Browse Ankylosing Spondylitis Trials in Baltimore →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsCOVID-19 TrialsLong COVID TrialsAll Conditions →

Ready to Join in Baltimore?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Baltimore, MD